FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “NewLeaf Brands’ Partners With Innovative Social Media Influencer Marketing Platform Herbfluence, Inc, Which Reaches Over 20,000,000 People.”
NewLeaf Brands Inc. (CSE: NLB) (OTC: NLBIF) (FSE: 0NF) and its wholly owned subsidiaries, We Are Kured, LLC and ReLyfe Brand, LLC are pleased to announce that the Company has entered into an agreement (the “Agreement”) with Herbfluence, Inc. Under the terms of the Agreement, Herbfluence has selected two of the Company’s CBD branded products to be included in the initial launch of the Herbfluence marketing platform on Monday, October 28, 2019. Herbfluence is an influencer marketplace for the Cannabis Industry. It is a smarter, simpler approach to advertising cannabis brands through social media influencers.
NewLeaf Brands, Inc. is an innovative Cannabidiol lifestyle Company. Through the Company’s wholly-owned subsidiaries We are Kured, LLC, Drink Fresh Water, LLC, ReLyfe Brand, LLC and TeaLief Brand, LLC the Company’s main business activities encompass the development, marketing, and distribution of CBD products (including vaporizer pens/cartridges, hot/cold tea, softgel capsules and beverages) throughout North America, South America, and Europe. In addition, NewLeaf Brands, Inc. has extensive retail and cultivation land investments in Oregon, USA.
Canada made headlines in 2018 after it became the second country in the world to completely legalize adult cannabis use. The country’s Prime Minister Justin Trudeau was a strong advocate for legalization and ultimately, the country decided to pass new legislation and initiate legal adult-use in late 2018. However, despite Canada’s legal market, the enormous U.S. market continues to cast a cloud over its northern neighbor, even though the U.S. has not yet moved to federally legalize cannabis. Instead, the U.S. government has granted states the jurisdiction to legalize cannabis for either medical or recreational purposes. And as of June 2019, 33 states and the District of Columbia allowed the use of cannabis for medical applications. Moreover, 11 of those states, including the District of Columbia have legalized adult recreational use. Overall, the U.S. is the primary global market driver because of its early adoption, dating back to the late 1990s when states such as California, Oregon, Alaska, and Washington were the first to implement a medicinal cannabis program. However, the industry was completely reshaped when Colorado and Washington legalized recreational cannabis in 2014. However, despite Colorado and Washington’s efforts, the topic of adult-use legalization is still dubious among world political leaders. Nonetheless, a handful of countries have decided to legalize medical cannabis. Specifically, most countries are using CBD-based products in their medical programs. CBD or cannabidiol is a chemical compound found within the hemp plant, which falls under the cannabis family. Regulators are more inclined to approve CBD because it does not cause any dependency or stimulate psychotropic effects, unlike THC. As a result, CBD is having prominent impact on global markets as regulators move to use it as an alternative to traditionally prescribed medications. According to data compiled by MarketsandMarkets, the global cannabis market was valued at USD 10.3 Billion in 2018. By 2023, the market is expected to reach USD 39.4 Billion while exhibiting a CAGR of 30.7% during the forecast period.
After the U.S. passed the Farm Bill in 2018, hemp-derived CBD products became the craze among consumers. Promptly, many companies decided to launch hemp grow houses throughout the country. Notably, hemp can be used for multiple purposes, including industrial manufacturing applications. However, nowadays, hemp is primarily associated with CBD-based health and wellness products. Typically, the hemp plant contains less than 0.3% THC, which is not enough to cause psychoactive effects. On the other hand, THC-dominant strains can pack as much as 30% or higher THC levels. And according to Marijuana Break, in 2018, estimates indicated that the average THC levels in strains were approximately 15%. In comparison, one of the highest CBD plants is Cannatonic, a strain with up to 12% CBD. However, Marijuana Break noted that your chances of successfully growing a high-CBD plant from a Cannatonic seed are less than 75%. Additionally, there is no way to produce more CBD content than the amount a plant genetically contains. Yet, cultivators can achieve high-CBD strains by selecting an ideal seed and treating it with optimal growing conditions. Generally, factors such as warm soil temperature, warm air temperature, and lower levels of water can potentially allow plants to unlock its full CBD capability. Moreover, positive general care and harvesting at a specific time can also result in higher CBD levels. The higher CBD content can then more effectively alleviate medical symptoms such as chronic pain, depression, stress, anxiety, and insomnia. And now, doctors throughout the U.S. are beginning to prescribe patients with CBD to treat their ailments. “It’s everything people believe to be good about marijuana. Without the downside of getting stoned,” said Bethany Gomez, Managing Director at Brightfield Group. “I’ve been doing market research for years and covered everything. This is definitely the craziest market I’ve ever covered.”
For more information, please visit: NewLeaf Brands, Inc.
For more corporate news on NewLeaf Brands, Inc., check out the Buzz on the Street
About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.